Testing of the Readability of Package Inserts at a Community Pharmacy
Rolf Brockmeyer a, Ludwig Steindl a, Ilsabé Behrens b, Sabine Gnekow b, Frank Verheyen c, and Martin Schulz c
Bayer Vital GmbH a, Leverkusen; Adler-Apotheke b, Hamburg; Center for Drug Information and Pharmacy Practice (ZAPP) of the Federal Union of German Associations of Pharmacists (ABDA) c, Eschborn (Germany)
The comprehensibility of package inserts is still being highlighted as a key concern by patients and consumer organisations. The German Drug Law (AMG) requires that patient information should be generally intelligible, in German and in easily legible print. In the runup to a decentralised marketing authorisation procedure, Bayer Vital investigated the readability of package inserts in conjunction with the Center for Drug Information and Pharmacy Practice (ZAPP) of the Federal Union of German Associations of Pharmacists (ABDA) and the Adler Pharmacy in Hamburg.
Key words Community pharmacy · Guideline on label and package leaf-let readability · Package insert · Patient